Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by Ingiboyon Nov 06, 2023 11:24am
111 Views
Post# 35719447

RE:RE:RE:RE:RE:Replicel Top Investors

RE:RE:RE:RE:RE:Replicel Top InvestorsToniZ1 we heard the bad news on Oct. 16th. It now 21 days later and we have heard crickets from the CEO or any of the Directors of the company.  I am not sure about you but my inference here is that they are struggling to come up with a plan moving forward.  Maybe they do have a plan but maybe they don't.  I would love to hang in here for the next few years to see a $1.00 or more per share but at this point I must admit i am a bit nervous.  Given the option of waiting years for my $1.00/share or just getting my money back, at this point I will take the $.25 which will return my investment with minimal to little profit and i will move on to a new investment. 
 Unlike others that have sold their shares in the $.06 - $.075 and moved on I am willing to wait to see where this goes to at least get my money back.
<< Previous
Bullboard Posts
Next >>